A 2021 review of studies noted that digestive side effects like nausea are often mild to moderate and tend to sharply decrease after week 20 of treatment
The FDA warned another Indian facility for widespread data integrity failures, inadequate manufacturing and cleaning validation, insufficient microbiological testing, and inaccurate drug listings
Despite these limitations, this study has notable strengths, including its large population size and direct usage of individual lab values, not just a pass / fail test result
For example, Rimonabant was withdrawn due to reports of suicidal thoughts and actions
Traducido por SuperSmart 10 mayo 2025 no tengo suficiente perspectiva para dar una opinin
Common side effects include nausea, vomiting, diarrhoea, constipation, abdominal discomfort, bloating, headache and fatigue